These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 28032234)

  • 1. The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases.
    Fabiani C; Sota J; Tosi GM; Franceschini R; Frediani B; Galeazzi M; Rigante D; Cantarini L
    Clin Rheumatol; 2017 Oct; 36(10):2307-2318. PubMed ID: 28032234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunology in clinical practice. XIII. Immune diseases of the eye].
    Ooijman FM; van der Lelij A
    Ned Tijdschr Geneeskd; 1998 Feb; 142(9):443-8. PubMed ID: 9562756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1.
    Goldbach-Mansky R
    Clin Exp Immunol; 2012 Mar; 167(3):391-404. PubMed ID: 22288582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1 blockade in autoinflammatory syndromes.
    Jesus AA; Goldbach-Mansky R
    Annu Rev Med; 2014; 65():223-44. PubMed ID: 24422572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monogenic Auto-inflammatory Syndromes: A Review of the Literature.
    Azizi G; Khadem Azarian S; Nazeri S; Mosayebian A; Ghiasy S; Sadri G; Mohebi A; Khan Nazer NH; Afraei S; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2016 Dec; 15(6):430-444. PubMed ID: 28129677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protean ocular involvement in monogenic autoinflammatory diseases: state of the art.
    Bascherini V; Granato C; Lopalco G; Emmi G; Vannozzi L; Bacherini D; Franceschini R; Iannone F; Salerni A; Molinaro F; Messina M; Frediani B; Selmi C; Rigante D; Cantarini L
    Clin Rheumatol; 2015 Jul; 34(7):1171-80. PubMed ID: 25833143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling inflammation: contemporary treatments for autoinflammatory diseases and syndromes.
    Sterba G; Sterba Y
    Dermatol Clin; 2013 Jul; 31(3):507-11. PubMed ID: 23827252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship between NALP3 and Autoinflammatory Syndromes.
    Campbell L; Raheem I; Malemud CJ; Askari AD
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatment options for cryopyrin-associated periodic syndromes.
    Landmann EC; Walker UA
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):855-864. PubMed ID: 28586272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Otological aspects of NLRP3-related autoinflammatory disorder focusing on the responsiveness to anakinra.
    Kim BJ; Kim YH; Lee S; Han JH; Lee SY; Seong J; Lee DH; Kim B; Park HR; Carandang M; Oh D; Oh SH; Kim JG; Lee S; Choi BY
    Rheumatology (Oxford); 2021 Mar; 60(3):1523-1532. PubMed ID: 33020839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New possibilities in therapy of ocular inflammation in rheumatic diseases].
    Razumova IY; Godzenko AA
    Vestn Oftalmol; 2022; 138(6):108-114. PubMed ID: 36573954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.
    Contreras-Ruiz L; Mir FA; Turpie B; Krauss AH; Masli S
    Exp Eye Res; 2016 Feb; 143():1-8. PubMed ID: 26463157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of autoinflammatory syndromes.
    Gattorno M; Martini A
    Curr Opin Pediatr; 2010 Dec; 22(6):771-8. PubMed ID: 20966753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses.
    Goldbach-Mansky R; Kastner DL
    J Allergy Clin Immunol; 2009 Dec; 124(6):1141-9; quiz 1150-1. PubMed ID: 20004775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of autoinflammatory syndromes: with an emphasis on hyper-IgD syndrome.
    van der Meer JW; Simon A
    Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii23-ii29. PubMed ID: 27856657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab.
    Ahmadi-Simab K; Lamprecht P; Nölle B; Ai M; Gross WL
    Ann Rheum Dis; 2005 Jul; 64(7):1087-8. PubMed ID: 15958765
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of interleukin-1β in NLRP12-associated autoinflammatory disorders and resistance to anti-interleukin-1 therapy.
    Jéru I; Hentgen V; Normand S; Duquesnoy P; Cochet E; Delwail A; Grateau G; Marlin S; Amselem S; Lecron JC
    Arthritis Rheum; 2011 Jul; 63(7):2142-8. PubMed ID: 21480187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study.
    Fabiani C; Vitale A; Emmi G; Lopalco G; Vannozzi L; Guerriero S; Gentileschi S; Bacherini D; Franceschini R; Frediani B; Galeazzi M; Iannone F; Tosi GM; Cantarini L
    Clin Rheumatol; 2017 Jan; 36(1):191-197. PubMed ID: 27981463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF inhibition for ophthalmic indications: current status and outlook.
    Rifkin LM; Birnbaum AD; Goldstein DA
    BioDrugs; 2013 Aug; 27(4):347-57. PubMed ID: 23568177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular Manifestations of Inherited Phospholipase-Cγ2-Associated Antibody Deficiency and Immune Dysregulation.
    Di Zazzo A; Tahvildari M; Florakis GJ; Dana R
    Cornea; 2016 Dec; 35(12):1656-1657. PubMed ID: 27442322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.